419 related articles for article (PubMed ID: 15457442)
1. The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.
Criswell LA; Lum RF; Turner KN; Woehl B; Zhu Y; Wang J; Tiwari HK; Edberg JC; Kimberly RP; Moreland LW; Seldin MF; Bridges SL
Arthritis Rheum; 2004 Sep; 50(9):2750-6. PubMed ID: 15457442
[TBL] [Abstract][Full Text] [Related]
2. The effect of HLA-DR on susceptibility to rheumatoid arthritis is influenced by the associated lymphotoxin alpha-tumor necrosis factor haplotype.
Newton J; Brown MA; Milicic A; Ackerman H; Darke C; Wilson JN; Wordsworth BP; Kwiatkowski D
Arthritis Rheum; 2003 Jan; 48(1):90-6. PubMed ID: 12528108
[TBL] [Abstract][Full Text] [Related]
3. The influence of a polymorphism at position -857 of the tumour necrosis factor alpha gene on clinical response to etanercept therapy in rheumatoid arthritis.
Kang CP; Lee KW; Yoo DH; Kang C; Bae SC
Rheumatology (Oxford); 2005 Apr; 44(4):547-52. PubMed ID: 15695296
[TBL] [Abstract][Full Text] [Related]
4. Dissection of class III major histocompatibility complex haplotypes associated with rheumatoid arthritis.
Newton JL; Harney SM; Timms AE; Sims AM; Rockett K; Darke C; Wordsworth BP; Kwiatkowski D; Brown MA
Arthritis Rheum; 2004 Jul; 50(7):2122-9. PubMed ID: 15248209
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis.
Meyer JM; Evans TI; Small RE; Redford TW; Han J; Singh R; Moxley G
J Rheumatol; 1999 May; 26(5):1024-34. PubMed ID: 10332964
[TBL] [Abstract][Full Text] [Related]
6. Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis.
Martínez A; Fernández-Arquero M; Pascual-Salcedo D; Conejero L; Alves H; Balsa A; de la Concha EG
Arthritis Rheum; 2000 Jun; 43(6):1366-70. PubMed ID: 10857796
[TBL] [Abstract][Full Text] [Related]
7. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
Kremer JM; Weinblatt ME; Bankhurst AD; Bulpitt KJ; Fleischmann RM; Jackson CG; Atkins KM; Feng A; Burge DJ
Arthritis Rheum; 2003 Jun; 48(6):1493-9. PubMed ID: 12794815
[TBL] [Abstract][Full Text] [Related]
8. Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset.
González-Gay MA; Hajeer AH; García-Porrúa C; Dababneh A; Thomson W; Ollier WE; Mattey DL
J Rheumatol; 2002 Feb; 29(2):271-5. PubMed ID: 11842822
[TBL] [Abstract][Full Text] [Related]
9. A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.
Miceli-Richard C; Comets E; Verstuyft C; Tamouza R; Loiseau P; Ravaud P; Kupper H; Becquemont L; Charron D; Mariette X
Ann Rheum Dis; 2008 Apr; 67(4):478-84. PubMed ID: 17673491
[TBL] [Abstract][Full Text] [Related]
10. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA
J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
[TBL] [Abstract][Full Text] [Related]
11. HLA-DRB1 alleles and shared amino acid sequences in disease susceptibility and severity in patients from eastern France with rheumatoid arthritis.
Toussirot E; Auge B; Tiberghien P; Chabod J; Cedoz JP; Wendling D
J Rheumatol; 1999 Jul; 26(7):1446-51. PubMed ID: 10405928
[TBL] [Abstract][Full Text] [Related]
12. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
13. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF
Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis.
Schotte H; Schlüter B; Drynda S; Willeke P; Tidow N; Assmann G; Domschke W; Kekow J; Gaubitz M
Ann Rheum Dis; 2005 Apr; 64(4):575-81. PubMed ID: 15345504
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
Bathon JM; Fleischmann RM; Van der Heijde D; Tesser JR; Peloso PM; Chon Y; White B
J Rheumatol; 2006 Feb; 33(2):234-43. PubMed ID: 16465653
[TBL] [Abstract][Full Text] [Related]
16. Interaction between RANKL and HLA-DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort.
Wu H; Khanna D; Park G; Gersuk V; Nepom GT; Wong WK; Paulus HE; Tsao BP
Arthritis Rheum; 2004 Oct; 50(10):3093-103. PubMed ID: 15476205
[TBL] [Abstract][Full Text] [Related]
17. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
Huizinga TW; Amos CI; van der Helm-van Mil AH; Chen W; van Gaalen FA; Jawaheer D; Schreuder GM; Wener M; Breedveld FC; Ahmad N; Lum RF; de Vries RR; Gregersen PK; Toes RE; Criswell LA
Arthritis Rheum; 2005 Nov; 52(11):3433-8. PubMed ID: 16255021
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor markers show sex-influenced association with rheumatoid arthritis.
Meyer JM; Han J; Moxley G
Arthritis Rheum; 2001 Feb; 44(2):286-95. PubMed ID: 11229458
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha 5'-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis.
Shibue T; Tsuchiya N; Komata T; Matsushita M; Shiota M; Ohashi J; Wakui M; Matsuta K; Tokunaga K
Arthritis Rheum; 2000 Apr; 43(4):753-7. PubMed ID: 10765919
[TBL] [Abstract][Full Text] [Related]
20. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis.
Mrazek F; Holla LI; Hutyrova B; Znojil V; Vasku A; Kolek V; Welsh KI; Vacha J; du Bois RM; Petrek M
Tissue Antigens; 2005 Feb; 65(2):163-71. PubMed ID: 15713215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
